MELISSA ASHLEY: Open Payments
NPI 1497720262 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 12 payments from 8 companies in 2025. Trend: 2023 $37 · 2024 $0 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Corcept Therapeutics | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: CAPLYTA, BREZTRI, Korlym, Cologuard Collection Kit, REXULTI, GEMTESA, JARDIANCE, Auvelity.
Industry payments across AL — which companies pay providers there.
